bromopyruvate has been researched along with Leukemia, Myeloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, AN; Kalra, N; Kumari, N; Rai, Y; Yadav, P | 1 |
| Aller, P; Boyano-Adánez, Mdel C; Brea, R; Calviño, E; de Blas, E; Estañ, MC; Rial, E; Sánchez-Martín, C | 1 |
2 other study(ies) available for bromopyruvate and Leukemia, Myeloid
| Article | Year |
|---|---|
Hexokinase II inhibition by 3-bromopyruvate sensitizes myeloid leukemic cells K-562 to anti-leukemic drug, daunorubicin.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Glucose; Hexokinase; Humans; Leukemia, Myeloid; Mitochondria; Pyruvates; Reactive Oxygen Species | 2019 |
Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: energy depletion, oxidative stress, and protein kinase activity modulation.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Drug Synergism; Energy Metabolism; Enzyme Activation; Glycolysis; Humans; Leukemia, Myeloid; MAP Kinase Signaling System; Mitochondria; Necrosis; Neoplasm Proteins; Oxidative Phosphorylation; Oxidative Stress; Protein Kinases; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Pyruvates; Up-Regulation | 2014 |